Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular cytogenetics: solid tumors and leukemia

J W Gray1, M G Pallavicini

  • 1Department of Laboratory Medicine, University of California, San Francisco 94143-0808.

Blood Cells
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to: 'Interpreting the guidelines for cleaning up after carbapenemase-producing organisms: the devil's in the dilution'.

The Journal of hospital infection·2016
Same author

The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.

Oncogene·2016
Same author

Cleaning up after carbapenemase-producing organisms.

The Journal of hospital infection·2016
Same author

Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer.

Oncogene·2016
Same author

The protected environment for high-risk haematology patients: as safe as we think?

The Journal of hospital infection·2016
Same author

How do you solve a problem like multidrug-resistant Gram-negative bacteria?

The Journal of hospital infection·2015
Same journal

In vitro and in vivo studies of stromal niches.

Blood cells·1994
Same journal

Differential manipulation of normal and chronic myeloid leukemia stem cell proliferation in vitro.

Blood cells·1994
Same journal

Enrichment for primitive hemopoietic progenitors of marrow cells from 5-fluorouracil-treated mice and normal mice.

Blood cells·1994
Same journal

Protein tyrosine phosphorylation in the regulation of hematopoiesis by receptors of the cytokine-receptor superfamily.

Blood cells·1994
Same journal

Lysis of blood platelets by human osteosarcoma cells in vitro.

Blood cells·1994
Same journal

Development of hemopoietic bone marrow within the ectopic bone induced by bone morphogenetic protein.

Blood cells·1994
See all related articles

Leukemia is a genetic disease where cell behavior and therapy response depend on genetic traits. New molecular tools like fluorescence in situ hybridization help analyze genetic evolution in leukemia.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Acute leukemia is extensively studied, leading to established understandings.
  • Leukemia is fundamentally a genetic disease, with cell behavior and treatment response linked to genetic makeup.
  • Despite advances, genotype-phenotype relationships in leukemia remain challenging to define.

Purpose of the Study:

  • To explore the power of novel molecular cytogenetic tools in analyzing leukemia's genetic evolution.
  • To investigate the application of fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH) in leukemia research.
  • To bridge the gap between genetic characteristics and cellular behavior in leukemic cells.

Main Methods:

  • Utilizing advanced molecular cytogenetic techniques.

Related Experiment Videos

  • Applying fluorescence in situ hybridization (FISH) for detailed genetic analysis.
  • Employing comparative genomic hybridization (CGH) to detect genomic alterations.
  • Leveraging existing knowledge from solid tumor studies.

    • Main Results:

    • New molecular cytogenetic tools offer powerful insights into leukemic cell genetic evolution.
    • FISH and CGH enable precise measurement of genetic changes in leukemia.
    • The study highlights the potential of these techniques to elucidate genotype-phenotype correlations.

    Conclusions:

    • Understanding the genetic underpinnings of leukemia is crucial for effective therapy.
    • Molecular cytogenetics provides advanced methodologies for dissecting leukemia's genetic landscape.
    • Future research should focus on applying these tools to better understand leukemia progression and treatment response.